• Blog
  • Human Platelet Lysate Market Growth Analysis

    Human Platelet Lysate Market Growth Analysis

    Human Platelet Lysate Market Growth Analysis
    Report code - SR1497 Delivery - 2 Weeks
    Human Platelet Lysate Market Growth, Trends, Dynamics & Market Insights: 2021-2026
    See more...

    Market Insights

    The Human Platelet Lysate Market is estimated to grow from USD 48.2 Million in 2020 to USD 59.8 Million by 2026 at a healthy CAGR of 3.7% during the forecast period.

    Wish to get a free sample? Register Here

    What is human platelet lysate?

    Human Platelet Lysate (HPL) is a non-animal derived cell culture growth supplement that is obtained from blood platelets after freezing and thawing. It contains abundant factors and cytokines required for cell growth and proliferation. Platelet lysate can be utilized as a source of growth for replacing bovine serum in a cell culture medium.

    Human Platelet Lysate Market Report Overview

    Market Size in 2026

    USD 59.8 Million

    Market Size in 2020

    USD 48.2 Million

    Market Growth (2021-2026)

    CAGR of 3.7%

    Base Year of Study

    2020

    Trend Period

    2016-2019

    Forecast Period

    2021-2026

    Key Players

    Key players operating in the human platelet lysate market are-

    • Merck KGaA (Germany)
    • Compass Biomedical Inc. (US)
    • Macopharma SA (France)
    • Mill Creek Life Sciences Llc.
    • Stemcell Technologies Inc. (Canada)
    • Zen-Bio, Inc.
    • Sclavo Diagnostics International Srl. (Italy)
    • Life Science Group Limited (Life Science Production) (India)
    • Trinova Biochem Gmbh (Germany)

    Market Dynamics

    Growing emphasis on funding & rise in research centers, government regulations, clinical and staff efficiency, product innovation, and user acceptance are some of the key driving factors propelling the growth of the human platelet lysate market during the review period. Also, rising awareness levels of blood donation coupled with increasing adoption of advanced blood collection & processing technology in developing countries is also anticipated to augment the human platelet lysate market growth.

    COVID-19 Impact

    The COVID-19 outbreak moderately affected the growth of the human platelet lysate market. Rising cases of coronavirus across the globe put a heavy strain on the healthcare sector. As the medical community is treating the infected patients, the research related to human platelet lysate was moderately impacted, thus resulting in fewer visits to clinics.

    To get the full scope of the report, Register Here

    Segments' Analysis

    Application Trends

    Based on application, the market has been bifurcated into research use and clinical use. The research use segment accounted for a substantial market share in 2020. The evolution of human platelet lysates has bolstered various experimental and clinical research studies. Also, growing government funding for life science-related projects and an increasing number of research centers and research institutes boost the segment growth.

    Regional Trends

    The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to the strong presence of well-developed healthcare infrastructure and favorable government initiatives. Moreover, rising innovations in technologically advanced products, immense per capita health expenditures, increasing numbers of chronic patients, which further proliferate the regional growth.

    To get the full scope of the report, Register Here

    Target Audience

    Here is the list of the group of customers that the market hopes to have the greatest opportunity to convert-

    • Distributors
    • Suppliers
    • Manufacturers
    • Logistics organizations
    • Government bodies

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What deliverables will you get in this report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth analysis of the Human Platelet Lysate Market

    How lucrative is the future?

    Market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional and country level historical data and forecasts

    Which are the most attractive market segments?

    Market segment analysis and forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirement?

    10% free customization

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

    Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to three players)
    • SWOT analysis of key players (up to three players)

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The human platelet lysate market is expected to witness an impressive growth of 3.7% CAGR in the coming years.

    Merck KGaA (Germany), Compass Biomedical Inc. (US), Macopharma SA (France), Mill Creek Life Sciences Llc., Stemcell Technologies Inc. (Canada), Zen-Bio, Inc., Sclavo Diagnostics Interna-tional Srl. (Italy), Life Science Group Limited (Life Science Production) (India), and Trinova Bio-chem Gmbh (Germany) are among the key players in the human platelet lysate market.

    The human platelet lysate market size is expected to reach USD 59.8 million in the foreseeable future.

    The research use segment accounted for a substantial share in the human platelet lysate market in 2020.

    North America is expected to remain dominant in the human platelet lysate market in the next five years.

    Growing emphasis on funding & rise in research centers, government regulations, clinical and staff efficiency, product innovation, and user acceptance are some of the key driving factors propelling the growth of the human platelet lysate market during the review period. Also, rising awareness levels of blood donation coupled with increasing adoption of advanced blood collection & processing technology in developing countries is also anticipated to augment the human platelet lysate market growth.